Rh (RH) EBITDA Margin (2011 - 2026)

Rh has reported EBITDA Margin for 16 years, with the latest figure at 4.28% in Q2 2026.

• On a quarterly basis, EBITDA Margin fell 259.0% year-over-year to 4.28% in Q2 2026; TTM through May 2026 was 10.67%, a 76.0% increase from a year earlier, with the FY2026 full-year figure at 11.26%, up 112.0% from the prior year.
• EBITDA Margin was 4.28% for Q2 2026 at Rh, down from 11.46% in the prior quarter.
• The five-year high for EBITDA Margin was 24.12% in Q1 2022, with the low at 4.28% in Q2 2026.
• Average EBITDA Margin over 5 years is 13.35%, with a median of 12.24% recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: EBITDA Margin tumbled 1277 bps in 2023, then jumped 568 bps in 2024.
• Over 5 years, EBITDA Margin stood at 19.59% in 2022, then sank by 65 bps to 6.82% in 2023, then soared by 83 bps to 12.5% in 2024, then dropped by 4 bps to 11.99% in 2025, then slumped by 64 bps to 4.28% in 2026.
• The last three EBITDA Margin figures came in at 4.28% (Q2 2026), 11.46% (Q1 2026), and 11.99% (Q4 2025), per Business Quant data.